Industries > Pharma > Global Contraceptive Devices Market Forecast to 2027

Back to Pharma Reports

Global Contraceptive Devices Market Forecast to 2027

Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

PUBLISHED: 20 December 2017

PAGES: 186

PRODUCT CODE: PHA0271

SUBMARKET: Medical Devices Next Generation Technologies

SKU: PHA0271 Categories: Medical Devices, Next Generation Technologies, Pharma

The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 186-page report you will receive 67 tables and 84 figures– all unavailable elsewhere.

The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Contraceptive Devices Market Forecast to 2027

• This report also breaks down the revenue forecast for the global contraceptive devices market by type:
– Condoms: Male and Female
– Diaphragms
– Sponges
– Vaginal Rigs
– Subdermal/Contraceptive Implants
– IUDs: Copper IUD and Hormonal IUD

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America: US & Canada
– Europe: the UK, Germany, France, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
– Rest of the World (RoW): Latin America, Middle East & Africa

• This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.

• Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:
– Bayer AG
– Reckitt Benckiser Group plc
– Merck Sharp & Dohme Corp.
– Church & Dwight Co., Inc.
– Teva Pharmaceutical Industries, Ltd.
– Allergan plc
– Ansell Limited (Now Humanwell)
– The Female Health Company (a division of VERU Inc.)
– Karex Industries
– Mayer Laboratories
– Kessel Medintim GmbH
– Okamato Industries, Inc.
– Agile Therapeutics, Inc.
– Eurogine S.L.

Visiongain’s study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.

Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Global Contraceptive Devices Market Overview

1.2 Overview of Findings

1.3 Global Contraceptive Devices Market Segmentation

1.4 Why You Should Read This Report

1.5 How This Report Delivers

1.6 Key Questions Answered by This Analytical Report Include:

1.7 Who is This Report For?

1.8 Methodology

1.8.1 Primary Research

1.8.2 Secondary Research

1.8.3 Market Evaluation & Forecasting Methodology

1.9 Frequently Asked Questions (FAQ)

1.10 Associated Visiongain Reports

1.11 About Visiongain

2. Introduction to the Contraceptive Devices Market

2.1 Contraceptive Devices Market Definition

2.2 Evolution of Contraceptive Devices

2.2.1 Snapshot: Evolution of Contraceptive Devices

2.2.2 Currently Available Contraceptive Devices

2.2.3 Future of Contraceptive Devices

2.2.4. Contraceptive Devices in Development

3. Global Contraceptive Devices Market Forecast to 2027

3.1 Global contraceptive Devices Market Forecast to 2027

3.2 Global Contraceptive Devices Market Dynamics, 2017

4. Global Contraceptive Devices Market by Type: Market Forecast to 2027

4.1 Global Condoms Market Forecast to 2027

4.2 Global Diaphragms Market Forecast to 2027

4.3 Global Sponges Market Forecast to 2027

4.4 Global Vaginal Rings Market Forecast to 2027

4.5 Global Subdermal Implants/ Contraceptive Implant Market Forecast to 2027

4.6 Global Intrauterine Devices/ Systems (IUD’s and IUS’s) Market Forecast to 2027

5. Leading National Markets Forecast to 2027

5.1 North America Contraceptive Devices Market Forecast to 2027

5.1.1 The U.S. Contraceptive Devices Market Forecast to 2027

5.1.2 Canada Contraceptive Devices Market Forecast to 2027

5.2 Europe Contraceptive Devices Market Forecast to 2027

5.2.1 U.K. Contraceptive Devices Market Forecast to 2027

5.2.2 Germany Contraceptive Devices Market Forecast to 2027

5.2.3 France Contraceptive Devices Market Forecast to 2027

5.2.4 Italy Contraceptive Devices Market Forecast to 2027

5.2.5 Rest of Europe Contraceptive Devices Market Forecast to 2027

5.3 Asia-Pacific Contraceptive Devices Market Forecast to 2027

5.3.1 China Contraceptive Devices Market Forecast to 2027

5.3.2 Japan Contraceptive Devices Market Forecast to 2027

5.3.3 India Contraceptive Devices Market Forecast to 2027

5.3.4 Rest of Asia-Pacific Contraceptive Devices Market Forecast to 2027

5.4 Rest of the World (ROW) Contraceptive Devices Market Forecast to 2027

5.4.1 Latin America Contraceptive Devices Market Forecast to 2027

5.4.2 Middle East & Africa Contraceptive Devices Market Forecast to 2027

6. Leading Companies in the Contraceptive Devices Market

6.1 Bayer AG

6.1.1 Bayer AG: Business Overview

6.1.2 Bayer AG: Financial Overview

6.1.3 Bayer AG: Product Portfolio

6.1.4 Bayer AG - Recent Developments (2014-2017)

6.1.5 Bayer AG - SWOT Analysis

6.2 Reckitt Benckiser Group plc

6.2.1 Reckitt Benckiser Group plc: Business Overview

6.2.2 Reckitt Benckiser Group plc: Financial Overview

6.2.3 Reckitt Benckiser Group plc: Product Portfolio

6.2.4 Reckitt Benckiser Group plc: Recent Developments (2014-2017)

6.2.5 Reckitt Benckiser Group plc: SWOT Analysis

6.3 Merck Sharp & Dohme Corp.

6.3.1 Merck Sharp & Dohme Corp.: Business Overview

6.3.2 Merck Sharp & Dohme Corp.: Financial Overview

6.3.3 Merck Sharp & Dohme Corp.: Product Portfolio

6.3.3 Merck Sharp & Dohme Corp.: SWOT Analysis

6.4 Church & Dwight Co., Inc.

6.4.1 Church & Dwight Co., Inc.: Business Overview

6.4.2 Church & Dwight Co., Inc.: Financial Overview

6.4.3 Church & Dwight Co., Inc.: Product Portfolio

6.4.4 Church & Dwight Co., Inc.: Recent Developments (2014-2017)

6.5 Teva Pharmaceuticals Industries, Ltd.

6.5.1 Teva Pharmaceuticals Industries, Ltd.: Business Overview

6.5.2 Teva Pharmaceuticals Industries, Ltd.: Financial Overview

6.5.3 Teva Pharmaceuticals Industries, Ltd.: Product Portfolio

6.5.4 Teva Pharmaceuticals Industries, Ltd.: Recent Developments (2014-2017)

6.6 Allergan, PLC.

6.6.1 Allergan, PLC.: Business Overview

6.6.2 Allergan, PLC.: Financial Overview

6.6.3 Allergan, PLC.: Product Portfolio

6.6.4 Allergan, PLC.: Recent Developments (2014-2017)

6.6.5 Allergan, PLC.: SWOT Analysis

6.7 Ansell Limited (Now Humanwell)

6.7.1 Ansell Limited (Now Humanwell): Business Overview

6.7.2 Ansell Limited (Now Humanwell): Financial Overview

6.7.3 Ansell Limited (Now Humanwell): Product Portfolio

6.7.4 Ansell Limited (Now Humanwell): Recent Developments (2014-2017)

6.7.5 Ansell Limited (Now Humanwell): SWOT Analysis

6.8 The Female Health Company (A division of VERU Inc.)

6.8.1 The Female Health Company (A division of VERU Inc.): Business Overview

6.8.2 The Female Health Company (A division of VERU Inc.): Financial Overview

6.8.3 The Female Health Company (A division of VERU Inc.): Product Portfolio

6.8.4 The Female Health Company (A division of VERU Inc.): Recent Developments (2014-2017)

6.9 Karex Industries

6.9.1 Karex Industries: Business Overview

6.9.2 Karex Industries: Financial Overview

6.9.3 Karex Industries: Product Portfolio

6.9.4 Karex Industries: Recent Developments (2014-2017)

6.9.5 Karex Industries: SWOT Analysis

6.10 Mayer Laboratories

6.10.1 Mayer Laboratories: Business Overview

6.10.2 Mayer Laboratories: Product Portfolio

6.11 Kessel Medintim GmbH

6.11.1 Kessel Medintim GmbH: Business Overview

6.11.2 Kessel Medintim GmbH: Product Portfolio

6.11.3 Kessel Medintim GmbH: Recent Developments (2014-2017)

6.12 Okamato Industries, Inc.

6.12.1 Okamato Industries, Inc.: Business Overview

6.12.2 Okamato Industries, Inc.: Product Portfolio

6.13 Agile Therapeutics, Inc.

6.13.1 Agile Therapeutics, Inc.: Business Overview

6.13.2 Agile Therapeutics, Inc.: Financial Overview

6.13.3 Agile Therapeutics, Inc.: Product Portfolio

6.14 Eurogine S.L.

6.14.1 Eurogine S.L.: Business Overview

6.14.2 Eurogine S.L.: Product Portfolio

7. Contraceptive Devices Market: Qualitative Analysis

7.1 SWOT Analysis

7.1.1 Global Contraceptive Devices Market Drivers

7.1.1.1 Availability of technologically advanced contraceptive devices

7.1.1.2 Rapidly growing population leading to high risk of sexually transmitted diseases (STDs) & HIV

7.1.1.3 Increasing awareness (campaigns/ programmes) and government initiatives related to contraceptive devices

7.1.2 Global Contraceptive Devices Market Weaknesses

7.1.2.1 Concerns associated with the use of contraceptive devices

7.1.2.2 High cost of contraceptives and increasing pricing pressure on manufacturers

7.1.2.3 Product recalls

7.1.3 Global Contraceptive Devices Market Opportunity

7.1.3.1 Focus on emerging markets

7.1.4 Global Contraceptive Devices Market Trend

7.1.4.1 Development of technologically advanced contraceptive devices

7.2 PEST Analysis

7.2.1 Political

7.2.2 Economic

7.2.3 Social

7.2.4 Technological

8. Conclusions and Recommendations

8.1 The Global Contraceptive Devices Market in 2016, 2017

and 2027

8.1.1 Current Leading Contraceptive Devices Segments

8.1.2 Leading Contraceptive Devices Companies

8.1.3 Leading Regional Markets

8.2 Global Contraceptive Devices Market Forecast 2016-2027

8.3 The Future of the Contraceptive Devices Market?

Appendices

Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B

Visiongain report evaluation form

List of Tables

Table 2.1 Contraceptive Devices, Pipeline Products, 2017

Table 3.1 Global Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 3.2 Global Contraceptive Devices Market Forecast by Type: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 3.3 Contraceptive Devices Market Forecast by Geography: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 4.1 Global Condoms Market Forecast by Gender: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 4.2 Global Diaphragm Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 4.3 Global Sponges Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 4.4 Global Vaginal Rings Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 4.5 Global Subdermal/ Contraceptive Implant Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 4.6 Global Intrauterine Devices/ System’s Market Forecast by type: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.1 Contraceptive Devices Market Forecast Segmented by Regional Market: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 5.2 North American Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 5.3 U.S. Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 5.4 Canada Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.5 Europe Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.6 U.K. Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.7 Germany Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.8 France Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.9 Italy Contraceptive Devices Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027

Table 5.10 Rest of Europe Contraceptive Devices Market Forecast: Revenue ($m, AGR (%), CAGR (%), 2016-2027

Table 5.11 Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.12 China Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.13 Japan Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.14 India Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.15 Rest of Asia-Pacific Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.16 Rest of the World Contraceptive Devices Market Forecast Segmented by National Market: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.17 Latin America Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 5.18 Middle East & Africa Contraceptive Devices Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2016-2027

Table 6.1 Bayer - Company Overview

Table 6.2 Bayer AG – Product Portfolio

Table 6.3 Bayer AG – Recent Developments

Table 6.4 Reckitt Benckiser Group plc – Company Overview

Table 6.5 Reckitt Benckiser Group plc – Product Portfolio

Table 6.6 Reckitt Benckiser Group plc – Recent Developments

Table 6.7 Merck Sharp & Dohme Corp.– Company Overview

Table 6.8 Merck Sharp & Dohme Corp.– Product Portfolio

Table 6.9 Church & Dwight Co., Inc. – Company Overview

Table 6.10 Church & Dwight Co., Inc. – Product Portfolio

Table 6.11 Church & Dwight Co., Inc. – Recent Developments

Table 6.12 Teva Pharmaceuticals Industries Ltd. – Company Overview

Table 6.13 Teva Pharmaceuticals Industries Ltd. – Product Portfolio

Table 6.14 Teva Pharmaceuticals Industries Ltd. – Recent Developments

Table 6.15 Allergan Inc. – Company Overview

Table 6.16 Allergan Inc. – Product Portfolio

Table 6.17 Allergan Inc. – Recent Developments

Table 6.18 Ansell – Company Overview

Table 6.19 Ansell – Product Portfolio

Table 6.20 Ansell – Recent Developments

Table 6.21 The Female Health Company – Company Overview

Table 6.22 The Female Health Company – Product Portfolio

Table 6.23 The Female Health Company – Recent Developments

Table 6.24 Karex Industries – Recent Developments

Table 6.25 Karex Industries – Product Portfolio

Table 6.26 Karex Industries – Recent Developments

Table 6.27 Mayer Laboratories – Recent Developments

Table 6.28 Mayer Laboratories – Product Portfolio

Table 6.29 Kessel Medintim Gmbh – Company Overview

Table 6.30 Kessel Medintim Gmbh – Product Portfolio

Table 6.31 Kessel Medintim Gmbh – Recent Developments

Table 6.32 Okamato Industries, Inc.– Company Overview

Table 6.33 Okamato Industries, Inc.– Product Portfolio

Table 6.34 Agile Therapeutics, Inc. – Company Overview

Table 6.35 Agile Therapeutics, Inc. – Product Portfolio

Table 6.36 Eurogine, S.L. – Company Overview

Table 6.37 Eurogine, SL – Product Portfolio

Table 7.1 List of Product Recalls

Table 7.2 Contraceptive Devices Approved and Available in 2016

List of Figures

Figure 1.1 Global Contraceptive Devices Market Segmentation Overview, 2017

Figure 2.1 Snapshot: Evolution of Contraceptive Devices

Figure 3.1 Global Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 3.2 Global Contraceptive Devices Market Forecast by Type: 2016-2027 ($m, AGR%)

Figure 3.3 Contraceptive Devices Market Forecast by Geography: 2016-2027 ($m, AGR%)

Figure 3.4 Contraceptive Devices Market Dynamics, 2017

Figure 4.1 Global Contraceptive Device Market by Type: Market Share (%), 2017

Figure 4.2 Global Contraceptive Device Market by Type: Market Share (%), 2022

Figure 4.3 Global Contraceptive Device Market by Type: Market Share (%), 2027

Figure 4.4 Global Condoms Market Forecast: 2016-2027 ($m, AGR%)

Figure 4.5 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2017

Figure 4.6 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2022

Figure 4.7 Global Condoms Contraceptive Device Market by Gender: Market Share (%), 2027

Figure 4.8Global Diaphragms Market Forecast: 2016-2027 ($m, AGR %)

Figure 4.9 Global Sponges Market Forecast: 2016-2027 ($m, AGR%)

Figure 4.10 Global Vaginal Rings Market: 2016-2027 ($m, AGR %)

Figure 4.11 Global Subdermal/ Contraceptive Implant Device Market: 2016-2027 ($m, AGR%)

Figure 4.12 Global Intrauterine Devices/ System’s Market Forecast by Type 2016-2027 ($m, AGR%)

Figure 4.13 Global Intrauterine Devices/System’s Market by Sub-Segment: Market Share (%), 2017

Figure 4.14 Global Intrauterine Devices/ System’s Market by Sub-Segment: Market Share (%), 2022

Figure 4.15 Global Intrauterine Devices/ System’s Market by Sub-Segment: Market Share (%), 2027

Figure 5.1 Contraceptive Devices Market Forecast Segmented by Regional Market: 2016-2027 ($m, AGR %)

Figure 5.2 Contraceptive Devices Market by Region: Market Share (%), 2017

Figure 5.3 Contraceptive Devices Market by Region: Market Share (%), 2022

Figure 5.4 Contraceptive Devices Market by Region: Market Share (%), 2027

Figure 5.5 North America Contraceptive Use by Type, 2015

Figure 5.6 Europe Contraceptive Use by Type, 2015

Figure 5.7 Asia Contraceptive Use by Type, 2015

Figure 5.8 Latin America & Caribbean Contraceptive Use by Type, 2015

Figure 5.9 Africa Contraceptive Use by Type, 2015

Figure 5.10 North American Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.11 North American Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($m, AGR %)

Figure 5.12 North American Contraceptive Devices Market by Country: Market Share (%), 2017

Figure 5.13 North American Contraceptive Devices Market by Country: Market Share (%), 2022

Figure 5.14 North American Contraceptive Devices Market by Country: Market Share (%), 2027

Figure 5.15 U.S. Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.16 Canada Contraceptive Devices Market Forecast: 2017-2027 ($m, AGR %)

Figure 5.17 Europe Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.18 Europe Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($, AGR %)

Figure 5.19 Europe Contraceptive Devices Market by Country: Market Share (%), 2017

Figure 5.20 Europe Contraceptive Devices Market by Country: Market Share (%), 2022

Figure 5.21 Europe Contraceptive Devices Market by Country: Market Share (%), 2027

Figure 5.22 U.K. Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.23 Germany Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.24 France Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.25 Italy Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.26 Rest of Europe Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.27 Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.28 Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027 ($m, AGR %)

Figure 5.29 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2017

Figure 5.30 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2022

Figure 5.31 Asia-Pacific Contraceptive Devices Market by Country: Market Share (%), 2027

Figure 5.32 China Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.33 Japan Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.34 India Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.35 Rest of Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.36 Rest of the World Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR%)

Figure 5.37 Rest of the World Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.38 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2017

Figure 5.39 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2022

Figure 5.40 Rest of the World Contraceptive Devices Market by Country: Market Share (%), 2022

Figure 5.41 Latin America Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 5.42 Middle East & Africa Contraceptive Devices Market Forecast: 2016-2027 ($m, AGR %)

Figure 6.1 Bayer AG – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.2 Bayer AG – SWOT Analysis

Figure 6.3 Reckitt Benckiser – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.4 Reckitt Benckiser Group plc – SWOT Analysis

Figure 6.5 Merck Sharp & Dohme Corp. (A Subsidiary of Merck & Co.) – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.6 Merck Sharp & Dohme Corp. – SWOT Analysis

Figure 6.7 Church & Dwight., Inc. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.8 Teva Pharmaceuticals Industries, Ltd. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.9 Allergan Inc. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.10 Allergan, PLC. – SWOT Analysis

Figure 6.11 Ansell Ltd. – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments and Geographical Segments

Figure 6.12 Ansell Limited (Now Humanwell) – SWOT Analysis

Figure 6.13 The Female Health Company – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Geographical Segments 2016

Figure 6.14 Karex Industries – Historical Revenue ($m), R&D Expenditure (%) 2012 – 2016, Business Segments & Geographical Segments

Figure 6.15 Karex Industries – SWOT Analysis

Figure 6.16 Agile Therapeutics – Historical R&D Revenue

Figure 8.1 Global Contraceptive Devices Market, 2016

Figure 8.2 Global Contraceptive Devices Market, 2017

Figure 8.3 Global Contraceptive Devices Market, 2027

Figure 8.4 Global Leading Contraceptive Devices Segments, 2016

Figure 8.5 Leading Regional Markets, 2016

7Med Industrie

Actavis PLC.

Agile Therapeutics

Almirall, S.A

Andromaco

Ansell Limited

Anterion Therapeutics

APCOR R&M, Belgium

Assembly Biosciences, Inc.

Bayer HealthCare

Beiersdorf AG

BioRings

CEMAG

Chongqing Medical Equipment Factory Co., Ltd.

Church & Dwight, Co. Inc.

CITIC Capital

CONRAD

ContraMed, LLC

Cupid Ltd.

Evestra, Inc.

FEI Technologies

Femsays Inc

Gedeon Richter Plc.

GeSea Biosciences

Grunenthal

HLL Lifecare Limited

HRA Pharma

Humanwell

Hydra Biosciences

Hypermarcs

Implementos Plasticos, Ltd., Mexico City

Innova Quality S.A.S

Karex Berhad

Karex Industries

Kessel Marketing & Vertriebs GmbH

Kessel Medintim Gmbh

Mayer Laboratories, Inc

Medicines360

Merck

Merck Sharp & Dohme Corp.

Meril Life Science Private Ltd

Microchips Biotech, Inc.

Mimetogen Pharmaceuticals, Inc.

Mona Lisa N.V.

Naurex, Inc.

OCON Medical Ltd.

Okamato Industries

Origami Healthcare Products, Inc.

Ottawa Hospital Research Institute (OHRI)

OvaTech

PATH

Poly-Med Inc

Pregna International Limited

ProMed Pharma

Prosan International B.V.

QPharma

Raymond Limited

Reckitt Benckiser Group

ReProtect Inc.

Shanghai Dahua Medical Apparatus Co., Ltd;

Shenyang Liren Medical & Technological Co.

Shepherd Medical Company

SILCS, Inc.

Teva Pharmaceuticals, Ltd.

The Female Health Company

Theramex

Tianjin Condombao Medical Polyurethane Tech. Co. Ltd

Tianjin Medical Instrument Factory

Veru Inc.

Vitality Medical Products

Yantai Family Planning Medicine & Apparatus Co. Ltd., China

Reckitt Benckiser Group, PLC

List of Organizations Mentioned in the Report

Albert Einstein College of Medicine

Centre Hospitalier Universitaire de Toulouse

CONRAD

Contrel Research, Belgium

DAIDS

FHI 360

Harvard University

Huazhong University of Science and Technology

Institute of Biomedical Engineering at Chinese Academy of Medical College

International Partnership for Microbicides

ISAF

Italian Medical Society for Contraception

Murdoch University

National Research Institute for Family Planning in Beijing

NIAID

NICHD

Northwestern University

Peking University

Rockefeller Foundation

RTI International; NICHD

Shandong Provincial Institute

Shandong University

Shanghai Institute of Planned Parenthood Research (SIPPR)

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)

Technology for Family Planning

Tehran University

Tongji Medical College

University of California at Berkeley

University of Cincinnati

University of Helsinki

University of Minnesota

University of North Carolina at Charlotte

University of Washington

USAID

Weill Cornell Medical College

WHO

Women's Health Alliance

Yale University

Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027

Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

27 September 2023

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

14 September 2023

READ

Industries > Pharma > Global Contraceptive Devices Market Forecast to 2027

Back to Pharma Reports

Global Contraceptive Devices Market Forecast to 2027

Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

Download sample pages

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

Our Clients